Using modeling to inform international guidelines for antiretroviral treatment
The costs and benefits of Option B+ for the prevention of mother-to-child transmission of HIV
Predicted levels of HIV drug resistance
The potential effects of changing HIV treatment policy on tuberculosis outcomes in South Africa
Modeling the impact of early antiretroviral therapy for adults coinfected with HIV and hepatitis B or C in South Africa
Dropout and re-enrollment
Exploring the population-level impact of antiretroviral treatment
How do different eligibility guidelines for antiretroviral therapy affect the cost–effectiveness of routine viral load testing in sub-Saharan Africa?
The role of mathematical modelling in the development of recommendations in the 2013 WHO consolidated antiretroviral therapy guidelines